Delivery Order SPE2DB22D2005-SPE2DB25FJSF0
- Not listed
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $29,315.47 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $66,535.75 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 30, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,989.71 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,524.09 delivery order on July 29, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count). This is a firm fixed-price, competitively awarded contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 30, 2025. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $3,989.84 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $2,535.89 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $19,371.24 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). The award is non-competitive and utilizes firm fixed-price pricing, with an ultimate completion date of August 18, 2025. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,633.02 to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. This is a firm fixed price, non-set-aside competitively awarded delivery order with an ultimate completion date of August 5, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSF0Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $98,086.77 for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract vehicle with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen fulfills critical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $98.1k | 8/20/25 |